Karl Andrew Garrill

This inventor holds 6 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Glaxo Wellcome Inc.. Active years: 2000-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl Andrew Garrill. Retrieved from https://idiyas.com/inventor/karl-andrew-garrill

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 83.3

Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 186(Granted Patents)

Company Filing History:

4 out of 2,198

Smithkline Beecham Corporation

Years Active: 2000-2004

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6679374 - Package for storing a pressurized container containing a drug (2004-01-20),

2. 6390291 - Method and package for storing a pressurized container containing a drug (2002-05-21),

3. 6352152 - Method and package for storing a pressurized container containing a drug (2002-03-05),

4. 6315112 - Method and package for storing a pressurized container containing a drug (2001-11-13),

5. 6179118 - Method and package for storing a pressurized container containing a drug (2001-01-30),

6. 6119853 - Method and package for storing a pressurized container containing a drug (2000-09-19),

Title: The Innovative Mind of Karl Andrew Garrill

Introduction

Karl Andrew Garrill, an inventive spirit based in Hertford, GB, has made significant contributions to the field of pharmaceutical packaging. With a total of six patents to his name, Garrill's work focuses on enhancing the safety and efficacy of drug storage. His latest patents reflect his dedication to improving how pressurized containers containing drugs are managed and stored.

Latest Patents

Among Garrill's notable inventions is a revolutionary package designed for storing a pressurized container filled with a drug formulation at a predetermined pressure. This innovative package effectively prevents the ingression of water vapor and particulate matter while allowing the egression of the propellant that may leak from the container. This dual functionality enhances the stability and reliability of drug formulations, marking a significant advancement in pharmaceutical packaging technology.

Career Highlights

Garrill's professional journey includes crucial roles at prominent companies such as SmithKline Beecham Corporation and Glaxo Wellcome Inc. His experience in these reputable organizations has undoubtedly shaped his inventive approach, allowing him to pioneer solutions that address common challenges in the industry.

Collaborations

Throughout his career, Garrill has collaborated with other talented professionals, including Richard J. Haan and Craig Steven Herman. These partnerships highlight the importance of teamwork in innovation, demonstrating how collaborative efforts can lead to groundbreaking inventions.

Conclusion

Karl Andrew Garrill's contributions to drug storage solutions through his innovative patents showcase his expertise and commitment to improving pharmaceutical practices. His work not only reflects individual creativity but also the impact of collaboration in the field of invention. As he continues to push the boundaries of innovation, Garrill remains a key figure in the realm of pharmaceutical packaging technology.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]